Date | Insider | Price | Amount |
---|---|---|---|
9-6-2023 Insider Buy |
Kevin Balthaser Chief Financial Officer |
$7.90 CAGR » |
$74,971.00 9,490 shares |
8-28-2023 Insider Buy |
James Loerop Chief Business Officer |
$6.80 CAGR » |
$99,958.71 14,705 shares |
3-17-2023 Insider Buy |
Douglas J. Manion Pres and CEO |
$7.86 CAGR » |
$49,532.49 6,300 shares |
3-9-2023 Insider Buy |
Douglas J. Manion Pres and CEO |
$7.74 CAGR » |
$50,277.50 6,500 shares |
10-22-2018 Insider Buy |
Anand Mehra Director |
$10.75 CAGR » |
$3,999,999.75 372,093 shares |
5-16-2018 Insider Buy |
Andrew Kenneth William Powell Director |
$19.12 CAGR » |
$9,560.00 500 shares |
5-7-2018 Insider Buy |
Frank Ruffo Chief Financial Officer |
$18.22 CAGR » |
$22,775.00 1,250 shares |
4-6-2018 Insider Buy |
Stephen A. Tullman Director |
$16.54 CAGR » |
$441,618.00 26,700 shares |
4-6-2018 Insider Buy |
Frank Ruffo Chief Financial Officer |
$16.59 CAGR » |
$20,737.50 1,250 shares |
4-5-2018 Insider Buy |
Neal Walker President and CEO |
$16.75 CAGR » |
$167,500.00 10,000 shares |
8-16-2017 Insider Buy |
Andrew N. Schiff Director |
$23.02 CAGR » |
$2,499,995.02 108,601 shares |
2-23-2016 Insider Buy |
RA CAPITAL MANAGEMENT, LLC >10% Owner |
$17.15 CAGR » |
$681,469.87 39,726 shares |
1-20-2016 Insider Buy |
RA CAPITAL MANAGEMENT, LLC >10% Owner |
$19.87 CAGR » |
$155,072.47 7,803 shares |
1-13-2016 Insider Buy |
RA CAPITAL MANAGEMENT, LLC >10% Owner |
$19.10 CAGR » |
$298,737.76 15,637 shares |
10-29-2015 Insider Buy |
RA CAPITAL MANAGEMENT, LLC >10% Owner |
$14.00 CAGR » |
$3,418,800.00 244,200 shares |
10-22-2015 Insider Buy |
RA CAPITAL MANAGEMENT, LLC >10% Owner |
$14.03 CAGR » |
$75,882.82 5,410 shares |
10-21-2015 Insider Buy |
RA CAPITAL MANAGEMENT, LLC >10% Owner |
$14.89 CAGR » |
$521,095.36 34,999 shares |
10-14-2015 Insider Buy |
RA CAPITAL MANAGEMENT, LLC >10% Owner |
$14.06 CAGR » |
$601,792.37 42,813 shares |
10-13-2015 Insider Buy |
FMR LLC >10% Owner |
$11.00 CAGR » |
$3,690,005.00 335,455 shares |
10-13-2015 Insider Buy |
Sofinnova Venture Partners VIII, L.P. >10% Owner |
$11.00 CAGR » |
$4,499,990.00 409,090 shares |
10-13-2015 Insider Buy |
Anand Mehra Director and >10% Owner |
$11.00 CAGR » |
$4,499,990.00 409,090 shares |
10-13-2015 Insider Buy |
VIVO VENTURES VII, LLC >10% Owner |
$11.00 CAGR » |
$4,999,995.00 454,545 shares |
10-13-2015 Insider Buy |
Albert Cha Director |
$11.00 CAGR » |
$4,999,995.00 454,545 shares |
10-8-2015 Insider Buy |
RA CAPITAL MANAGEMENT, LLC >10% Owner |
$10.86 CAGR » |
$24,289,919.53 2,237,130 shares |
10-7-2015 Insider Buy |
Albert Cha Director |
$11.00 CAGR » |
$146,872.00 13,352 shares |
10-7-2015 Insider Buy |
VIVO VENTURES VII, LLC >10% Owner |
$11.00 CAGR » |
$146,872.00 13,352 shares |
Also See: Institutional Holders of ACRS
Also See: SEC filings
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 09/07/2023 | |
End date: | 04/26/2024 | |
Start price/share: | $7.57 | |
End price/share: | $1.20 | |
Dividends collected/share: | $0.00 | |
Total return: | -84.15% | |
Annualized Gain: | -132.39% | |
Starting investment: | $10,000.00 | |
Ending investment: | $1,585.00 | |
Years: | 0.64 |
Aclaris Therapeutics Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.), and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these categories, but instead file their holdings quarterly on the latest form 13F filings. While recent Aclaris Therapeutics insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding ACRS
Free ACRS Email Alerts: Get Dividend Alerts Get SEC Filing Alerts |
Other companies seeing insider buying close in time to when the Aclaris Therapeutics Insider Buying occurred are:
Vicor Insider Buying |